Details
Product Name in the RMS: Quetiapin "Hexal"
MR Number: DK/H/2334/002
Date of outcome: 11.11.2014
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Additional Strength/Form Generic Chemical Substance Prescription Only |
Active Substances |
quetiapine 150 mg |
Form | Prolonged release tablet |
MA Holder in the RMS |
Hexal A/S Edvard Thomsens Vej 14 2300 København S Denmark |
RMS | Denmark |
Date of last change | 03.03.2020 |
ATC-Code |
N05AH04 Quetiapine |
CMS Country | Domestic Product Name |
---|---|
Austria | |
Finland | |
Germany | Quetiapin Pharmathen 150 mg Retardtabletten |
Greece | QUETIAPINE/HEXAL |
Iceland | |
Italy | |
Luxembourg | |
Netherlands | |
Poland | Kvelux SR |
Portugal | |
Romania | Netiapin 150 mg comprimate cu eliberare prelungită |
Slovenia | |
Sweden | |
United Kingdom |
Documents | |
---|---|
PAR: | DK_H_2334_002_PAR_1of2.pdf (25.01.2018) |
PAR: | DK_H_2334_002_PAR_2of2.pdf (25.01.2018) |
PARSummary: | DK_H_2334_002_PARSummary.pdf (26.01.2016) |
FinalSPC: | DK_H_2334_002_FinalSPC.pdf (31.08.2018) |
FinalPL: | DK_H_2334_002_FinalPL.pdf (31.08.2018) |
FinalLabelling: | DK_H_2334_002_FinalLabelling.pdf (02.03.2015) |
Finalised Product Information: | DK_H_2334_002_FinalPI_1of2.pdf (20.12.2018) |
Finalised Product Information: | DK_H_2334_002_FinalPI_2of2.pdf (20.12.2018) |